EMEA-001523-PIP02-14-M02

Key facts

Invented name
Tremfya
Active substance
guselkumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0129/2018
PIP number
EMEA-001523-PIP02-14-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Janssen Cilag International NV

Tel. +3214602111
E-mail: contact@Janssen-emea.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating